NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Holder | Stake |
|---|---|
| Pinfold Overseas | 6.39% |
| Morepen Laboratories | 1.02% |
| Document | Date |
|---|---|
| Annual report FY2026 MOREPEN LABORATORIES LIMITED – ANNUAL REPORT FY 2025-26 HEADLINE NUMBERS • Revenue from Operations (Standalone): ₹168,119.50 Lakhs (FY2026) vs ₹155, | 2026-09-02 |
| Investor presentation · Q1 FY27 MOREPEN LABORATORIES LIMITED – Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Revenue: Rs. 575.31 Crores in Q1 FY27, up 34% YoY (Q1 FY26: Rs. 429.64 Cr | 2026-08-04 |
| Quarterly results · Q1 FY27 MOREPEN LABORATORIES LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 FY2027 (Quarter ended 30 June 2026) Consolidated Results: - Revenue from op | 2026-08-04 |
| Investor presentation · Q4 FY26 MOREPEN LABORATORIES LIMITED – Q4 & FY26 INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Total Revenue: Rs. 1,703 Crore (8% growth vs FY25's Rs. 1,570 Cror | 2026-05-27 |
| Quarterly results · Q4 FY26 MOREPEN LABORATORIES LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Net Profit (Full Year FY2025-26): Rs. 9,487.68 lakhs • Net Profit (Q4 FY2025-26): | 2026-05-26 |
| Quarterly results · Q3 FY26 MOREPEN LABORATORIES LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 FY2025-26 (Quarter ended 31 Dec 2025) – Consolidated: - Revenue from operat | 2026-02-10 |
| Investor presentation MOREPEN LABORATORIES LIMITED – Q3 FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Gross Revenue (Standalone): Rs. 462 crores, up 23% QoQ and 13% YoY from Rs | 2026-02-10 |
| Investor presentation · Q2 FY26 MOREPEN LABORATORIES LIMITED – Q2 FY26 INVESTOR SUMMARY HEADLINE NUMBERS • Q2 FY26 Standalone Gross Revenue: Rs. 374 crores (vs Rs. 388 crores in Q2 | 2025-11-14 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹0.20 / share ex-date Sep 18, 2026 · record Sep 19, 2026 | 2026-09-18 |
| Announcement | Date |
|---|---|
| First phase of manufacturing capacity expansion completed ahead of schedule Morepen Laboratories Limited, a pharmaceutical company, has successfully completed the first phase of its manufacturing capacity expansion ahead of schedule. The company's installed reactor | 2026-09-07 |
| Received new orders/contracts Morepen Laboratories Limited has informed the Exchange about Bagging/Receiving of orders/contracts | 2026-02-23 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Morepen Laboratories Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.